Format
Items per page
Sort by

Send to:

Choose Destination

Results: 1 to 20 of 168

Similar articles for PubMed (Select 18664606)

1.

Postdischarge oral versus injectable anticoagulation following major orthopedic surgery.

Shorr AF, Nutescu EA, Farrelly E, Horblyuk R, Happe LE, Franklin M.

Ann Pharmacother. 2008 Sep;42(9):1222-8. doi: 10.1345/aph.1L113. Epub 2008 Jul 29.

PMID:
18664606
2.

Burden of deep vein thrombosis in the outpatient setting following major orthopedic surgery.

Nutescu EA, Shorr AF, Farrelly E, Horblyuk R, Happe LE, Franklin M.

Ann Pharmacother. 2008 Sep;42(9):1216-21. doi: 10.1345/aph.1L135. Epub 2008 Jul 8.

PMID:
18611992
3.

Decreased venous thromboembolism with injectable vs oral anticoagulation after discharge for major orthopedic surgery.

Kwong LM, Happe LE, Horblyuk R, Farrelly E.

J Arthroplasty. 2008 Sep;23(6 Suppl 1):25-30. doi: 10.1016/j.arth.2008.05.017.

PMID:
18722300
4.

Cost and occurrence of thrombocytopenia in patients receiving venous thromboembolism prophylaxis following major orthopaedic surgeries.

Happe LE, Farrelly EM, Stanford RH, Sarnes MW.

J Thromb Thrombolysis. 2008 Oct;26(2):125-31. Epub 2007 Nov 24.

PMID:
18034323
5.

Economic and clinical evaluation of fondaparinux vs. enoxaparin for thromboprophylaxis following general surgery.

Farias-Eisner R, Horblyuk R, Franklin M, Lunacsek OE, Happe LE.

Curr Med Res Opin. 2009 May;25(5):1081-7. doi: 10.1185/03007990902837117 .

PMID:
19298219
6.

Comparison of cost, effectiveness, and safety of injectable anticoagulants used for thromboprophylaxis after orthopedic surgery.

Shorr AF, Sarnes MW, Peeples PJ, Stanford RH, Happe LE, Farrelly E.

Am J Health Syst Pharm. 2007 Nov 15;64(22):2349-55.

PMID:
17989444
7.

Need to improve thromboprophylaxis across the continuum of care for surgical patients.

Amin AN, Lin J, Ryan A.

Adv Ther. 2010 Feb;27(2):81-93. doi: 10.1007/s12325-010-0015-8.

PMID:
20390389
8.

Venous thromboembolism after orthopedic surgery: implications of the choice for prophylaxis.

Shorr AF, Kwong LM, Sarnes M, Happe L, Farrelly E, Mody-Patel N.

Thromb Res. 2007;121(1):17-24. Epub 2007 Apr 20.

PMID:
17449088
9.
10.

Outpatient treatment of venous thromboembolism with low-molecular-weight heparin: an economic evaluation.

Huse DM, Cummins G, Taylor DC, Russell MW.

Am J Manag Care. 2002 Jan;8(1 Suppl):S10-6.

11.

Economic evaluation of enoxaparin for anticoagulation in early cardioversion of persisting nonvalvular atrial fibrillation: a statutory health insurance perspective from Germany.

Sch├Ądlich PK, Schmidt-Lucke C, Huppertz E, Lehmacher W, Nixdorff U, Stellbrink C, Brecht JG.

Am J Cardiovasc Drugs. 2007;7(3):199-217.

PMID:
17610347
12.

Clinical and economic outcomes in patients at risk of venous thromboembolism receiving appropriate enoxaparin or unfractionated heparin prophylaxis.

Amin AN, Lin J, Lenhart G, Schulman KL.

Thromb Haemost. 2009 Aug;102(2):321-6. doi: 10.1160/TH09-03-0147.

PMID:
19652883
13.

Thromboembolic consequences of subtherapeutic anticoagulation in patients stabilized on warfarin therapy: the low INR study.

Clark NP, Witt DM, Delate T, Trapp M, Garcia D, Ageno W, Hylek EM, Crowther MA; Warfarin-Associated Research Projects and Other Endeavors Consortium.

Pharmacotherapy. 2008 Aug;28(8):960-7. doi: 10.1592/phco.28.8.960.

PMID:
18657012
14.

Use of emerging oral anticoagulants in clinical practice: translating results from clinical trials to orthopedic and general surgical patient populations.

Merli G, Spyropoulos AC, Caprini JA.

Ann Surg. 2009 Aug;250(2):219-28. doi: 10.1097/SLA.0b013e3181ae6dbe. Review.

PMID:
19638915
15.
16.

Extended thromboprophylaxis with low-molecular-weight heparins after hospital discharge in high-risk surgical and medical patients: a review.

Huo MH, Muntz J.

Clin Ther. 2009 Jun;31(6):1129-41. doi: 10.1016/j.clinthera.2009.06.002. Review.

PMID:
19695383
17.

Comparison of injectable anticoagulants for thromboprophylaxis after cancer-related surgery.

Changolkar A, Menditto L, Shah M, Puto K, Farrelly E.

Am J Health Syst Pharm. 2014 Apr 1;71(7):562-9. doi: 10.2146/ajhp120711.

PMID:
24644116
18.
19.

Dalteparin versus enoxaparin for venous thromboembolism prophylaxis in acute spinal cord injury and major orthopedic trauma patients: 'DETECT' trial.

Slavik RS, Chan E, Gorman SK, de Lemos J, Chittock D, Simons RK, Wing PC, Ho SG.

J Trauma. 2007 May;62(5):1075-81; discussion 1081.

PMID:
17495705
20.

Outcomes of oral anticoagulant therapy managed by telephone vs in-office visits in an anticoagulation clinic setting.

Wittkowsky AK, Nutescu EA, Blackburn J, Mullins J, Hardman J, Mitchell J, Vats V.

Chest. 2006 Nov;130(5):1385-9.

PMID:
17099014
Format
Items per page
Sort by

Send to:

Choose Destination

Supplemental Content

Write to the Help Desk